-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, L0l3hnWYD+J8bIRdQ1Y8BfgYI1hPl5mgoeKdbBlUI1ZGUy88wLuKhsEdmptkD8d+ SIcW9E3b5QzUg+9mH6rVxw== 0001209191-04-014497.txt : 20040305 0001209191-04-014497.hdr.sgml : 20040305 20040305114329 ACCESSION NUMBER: 0001209191-04-014497 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20040303 FILED AS OF DATE: 20040305 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: AMPER LINDA E CENTRAL INDEX KEY: 0001220024 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-15190 FILM NUMBER: 04650929 MAIL ADDRESS: STREET 1: C/O OSI PHARMACEUTICALS INC STREET 2: 58 S SERVICE RD CITY: MELVILLE STATE: NY ZIP: 11747 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: OSI PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000729922 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 133159796 STATE OF INCORPORATION: DE FISCAL YEAR END: 0930 BUSINESS ADDRESS: STREET 1: 58 SOUTH SERVICE RD. STREET 2: SUITE 110 CITY: MELVILLE STATE: NY ZIP: 11747 BUSINESS PHONE: 631-962-2000 MAIL ADDRESS: STREET 1: 58 SOUTH SERVICE RD. STREET 2: SUITE 110 CITY: MELVILLE STATE: NY ZIP: 11747 FORMER COMPANY: FORMER CONFORMED NAME: ONCOGENE SCIENCE INC DATE OF NAME CHANGE: 19920703 4 1 doc4.xml FORM 4 SUBMISSION X0201 4 2004-03-03 0 0000729922 OSI PHARMACEUTICALS INC OSIP 0001220024 AMPER LINDA E C/O OSI PHARMACEUTICALS, INC. 58 SOUTH SERVICE ROAD, SUITE 110 MELVILLE NY 11747 0 1 0 0 VP Human Resources and Admin. Common Stock 2004-03-03 4 M 0 4203.0000 21.5500 A 4203.0000 D Common Stock 2004-03-03 4 S 0 4203.0000 43.0000 D 0 D Stock Option (Right to Buy) 21.5500 2004-03-03 4 M 0 4203.0000 0 D 2003-06-12 2012-06-11 Common Stock 4203.0000 6997.0000 D One third of the stock option became exercisable one year after the date of the grant and the remainder vested ratably on a monthly basis over the succeeding 24 months. The stock option was granted pursuant to one of the Issuer's incentive and non-qualified stock option plans and is exempt under Rule 16b-3. Includes only options with the same termination date. Robert L. Van Nostrand by Power of Attorney 2004-03-05 -----END PRIVACY-ENHANCED MESSAGE-----